Epoetin delta
Alternative Names: Dynepo; GA-EPO; Gene-activated epoetin alfa; Gene-activated epoetin alpha; Gene-activated erythropoietin; HMR 4396; MDL 104396; Recombinant human erythropoietin δLatest Information Update: 25 Sep 2021
At a glance
- Originator sanofi-aventis; Shire Pharmaceuticals Group
 - Developer sanofi-aventis; Shire; Shire plc
 - Class Antianaemics; Recombinant erythropoietins
 - Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 - New Molecular Entity No
 
Highest Development Phases
- Market Withdrawal Anaemia
 
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
 - 31 Dec 2008 Discontinued - Registered for Anaemia in European Union (IV)
 - 31 Dec 2008 Discontinued - Registered for Anaemia in European Union (SC)